The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...
The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved ...
The Broadway icon said he’s a “great believer” in the weight-loss medication, which helped him after he weighed 310 lbs.
Tirzepatide, the active ingredient in both Mounjaro for type 2 diabetes and Zepbound for weight loss, was in short supply for ...
An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...